Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
84.74
+0.63 (0.74%)
Nov 21, 2024, 3:59 PM EST - Market closed

Medtronic Revenue by Segment

Period Ending Sep 29, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 29, 2023Jun 29, 2023Apr 27, 2023Jan 26, 2023Oct 27, 2022Jul 28, 2022Apr 28, 2022Jan 27, 2022Oct 28, 2021Jul 29, 2021Apr 29, 2021Jan 28, 2021
Cardiovascular
12.34B 12.16B 12.00B 11.47B 11.32B 11.11B - 11.22B 11.19B
Cardiovascular Growth
9.03% 9.48% 7.00% 2.52% 0.64% -2.76% - -1.33% -1.24%
Neuroscience
9.53B 9.37B 9.27B 9.11B 8.94B 8.77B - 8.85B 8.74B
Neuroscience Growth
6.62% 6.87% 4.79% 4.19% 2.84% -0.17% - 0.79% -0.19%
Medical Surgery
8.40B 8.41B 8.45B 8.47B 8.39B 8.25B - 8.44B 8.59B
Medical Surgery Growth
0.10% 1.98% 0.17% -1.47% -4.91% -9.79% - -8.76% -7.33%
Diabetes
2.57B 2.49B 2.42B 2.40B 2.31B 2.25B - 2.26B 2.28B
Diabetes Growth
10.98% 11.00% 7.02% 5.27% 0.30% -3.98% - -5.19% -6.41%

Revenue by Geography

Period Ending Sep 29, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 29, 2023Jun 29, 2023Apr 27, 2023Jan 26, 2023Oct 27, 2022Jul 28, 2022Apr 28, 2022Jan 27, 2022Oct 28, 2021Jul 29, 2021Apr 29, 2021Jan 28, 2021Oct 29, 2020Jul 30, 2020Apr 23, 2020Jan 23, 2020Oct 24, 2019Jul 25, 2019Apr 25, 2019Jan 24, 2019Oct 25, 2018Jul 26, 2018
US
16.85B 16.72B 16.56B 16.70B 16.64B 16.53B 16.37B 15.99B
US Growth
1.27% 1.14% 1.15% 4.38% 4.83% 4.63% 1.48% -1.39%
Rest of World
16.15B 15.86B 15.80B 15.62B 15.32B 15.03B 14.85B 14.78B
Rest of World Growth
5.40% 5.52% 6.38% 5.72% 2.56% -1.60% -4.49% -5.06%

Operating Expense Breakdown

Period Ending Sep 29, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 29, 2023Jun 29, 2023
Selling, General, and Administrative
10.85B 10.78B 10.74B 10.59B 10.53B 10.46B
Selling, General, and Administrative Growth
3.04% 3.04% 3.09% 2.12% 2.09% 1.44%
Research and Development
2.74B 2.74B 2.74B 2.70B 2.69B 2.67B
Research and Development Growth
1.82% 2.69% 1.48% -0.26% 0.22% -0.60%
Amortization
1.67B 1.68B 1.69B 1.70B 1.71B 1.70B
Amortization Growth
-2.52% -1.58% -0.35% -0.82% -0.18% -0.99%
Other Expenses
461.00M 464.00M 464.00M 43.00M -99.00M -165.00M
Restructuring
209.00M 219.00M 226.00M 408.00M 426.00M 416.00M
Restructuring Growth
-50.94% -47.36% -39.89% 270.91% 407.14% 550.00%
Litigation
- 190.00M 149.00M - 75.00M 10.00M
Litigation Growth
- 1,800.00% - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.